Phase 3 TB vaccine trial gets under way in SA

SA’s high TB burden and strong clinical trial infrastructure allows it to play a key role in the trial, which aims to enrol 20,000 volunteers

RMB Ventures and Bopa Moruo buy majority stake in Icon Oncology

Icon has clinical protocols, formularies and funding models used by more than half the medical scheme market

Eli Lilly signs deal with Amazon to deliver medicines

Drugmaker is also considering partnership with a retail pharmacy to offer a collect option for customers

Probe clears Mediclinic of billing fraud

The ENSafrica investigation included interviews with hospital staff and a review of more than 120,000 emails and documents

Novo Nordisk to present updates on trial drug and Wegovy supply issue

The company is racing to increase output of the weight-loss drug Wegovy amid shortages

WATCH: Aspen interim earning drop 6%

Business Day TV speaks to CEO Stephen Saad

Aspen aims to put loss-making factories to work

Drugmaker expects to finalise deals within the next six months to help use idle capacity

Life Healthcare to pay R6/share special dividend

Payout is part of the proceeds of the sale of group’s interest in Alliance Medical Group

JSE imposes public censure on Advanced Health founder Carl Grillenberger

Grillenberger bought shares when Advanced Health was trading under a cautionary and without the required clearance

Moderna gets earnings boost in fourth quarter

Pharmaceutical and biotechnology company outlines plans for experimental respiratory syncytial virus vaccine to offset decline in sales of its Covid vaccine

Indian pharma firms start making generic versions of weight-loss jabs

Novo Nordisk’s patents for Wegovy expire in China in 2026, in Japan and Europe in 2031 and in the US in 2032

Port congestion hurt Adcock Ingram’s over-the-counter supplies

HEPS rose 1%, benefiting from a buyback of 1.7-million shares due to a tough environment

Shareholder pressure behind R21bn sale of UK business, says Life Healthcare CEO

Peter Wharton-Hood says shareholders preferred to get dividends rather than wait for long-term rewards

Johnson & Johnson in deal to allow sales of generics

Alvotech settles with J&J to launch Stelara biosimilar in Europe and Canada

Biogen misses estimates for fourth-quarter profit

Firm returned the rights for its Alzheimer’s drug and had soft sales of its multiple sclerosis drug

Ascendis offer is fair, says new BDO report

Financial advisory firm BDO agrees with offer of 80c a share